This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Evaluation of AcrySof IQ Vivity Extended Vision Intraocular Lenses

Sponsored by Alcon Research

About this trial

Last updated 7 months ago

Study ID

ILI875-I001

Status

Not yet recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
22+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Started 6 months ago

What is this trial about?

The purpose of this post-market study is to describe the long-term safety and performance of AcrySof IQ Vivity and AcrySof IQ Vivity Toric intraocular lens (IOL) models in a real-world setting through routine clinical practice.

What are the Participation Requirements?

Key Inclusion Criteria:

- 22 years old or older at Visit 1.

- Able to understand and sign an approved informed consent form.

- Implantation of AcrySof IQ Vivity and/or Vivity Toric IOL models in both eyes for 3
to 5 years prior to enrollment.

- Documented medical history and required pre-operative baseline information available
for retrospective data collection.

- Other protocol-specified inclusion criteria may apply.

Key Exclusion Criteria:

- Corneal refractive surgery after AcrySof Vivity or AcrySof Vivity Toric IOL
implantation.

- Pregnant or nursing at the time of enrollment.

- Childbirth after IOL implantation.

- Other protocol-specified exclusion criteria may apply.

Locations

Location

Status